Back
Phathom Pharmaceuticals Stock Price Chart
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
62
PHAT
Phathom Pharmaceuticals
Last Price:
18.71
Seasonality Move:
-9.67%
7 Day Trial
ALL ACCESS PASS
$
7
Hint at where the next big move in the market will be this month
Spot the next big move with this free book from a hedge fund manager- The current trend is moderately bullish and PHAT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Phathom Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.58 | Buy |
| 20-day SMA: | 16.79 | Buy |
| 50-day SMA: | 13.77 | Buy |
| 200-day SMA: | 10.45 | Buy |
| 8-day EMA: | 18.47 | Buy |
| 20-day EMA: | 16.97 | Buy |
| 50-day EMA: | 14.61 | Buy |
| 200-day EMA: | 11.63 | Buy |
Phathom Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.64 | Buy |
| Relative Strength Index (14 RSI): | 71.51 | Buy |
| Chaikin Money Flow: | 686596 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.56 - 18.4) | Buy |
| Bollinger Bands (100): | (9.43 - 14.73) | Buy |
Phathom Pharmaceuticals Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Phathom Pharmaceuticals Stock
Is Phathom Pharmaceuticals Stock a Buy?
- Phathom Pharmaceuticals share price is 19.25 while PHAT 8-day simple moving average is 18.58, which is a Buy signal.
- The stock price of PHAT is 19.25 while Phathom Pharmaceuticals 20-day SMA is 16.79, which makes it a Buy.
- Phathom Pharmaceuticals 50-day simple moving average is 13.77 while PHAT share price is 19.25, making it a Buy technically.
- PHAT stock price is 19.25 and Phathom Pharmaceuticals 200-day simple moving average is 10.45, creating a Buy signal.
PHAT Technical Analysis vs Fundamental Analysis
Buy
62
Phathom Pharmaceuticals (PHAT)
is a Buy
Is Phathom Pharmaceuticals a Buy or a Sell?
-
Phathom Pharmaceuticals stock is rated a Buy
The current Phathom Pharmaceuticals [PHAT] share price is $19.25. The Score for PHAT is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
Phathom Pharmaceuticals Stock Info
Market Cap:
1.31B
Price in USD:
19.25
Share Volume:
1.29M
Phathom Pharmaceuticals 52-Week Range
52-Week High:
19.68
52-Week Low:
6.07
Buy
62
Phathom Pharmaceuticals (PHAT)
is a Buy
Phathom Pharmaceuticals Share Price Forecast
-
What is the Phathom Pharmaceuticals stock price today?
The Phathom Pharmaceuticals stock price is 19.25 USD today. -
Will PHAT stock go up or go down?
Phathom Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Phathom Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Phathom Pharmaceuticals is not overvalued.
Is Phathom Pharmaceuticals Stock a Buy?
- Phathom Pharmaceuticals share price is 19.25 while PHAT 8-day exponential moving average is 18.47, which is a Buy signal.
- The stock price of PHAT is 19.25 while Phathom Pharmaceuticals 20-day EMA is 16.97, which makes it a Buy.
- Phathom Pharmaceuticals 50-day exponential moving average is 14.61 while PHAT share price is 19.25, making it a Buy technically.
- PHAT stock price is 19.25 and Phathom Pharmaceuticals 200-day simple moving average is 11.63, creating a Buy signal.
Fundamental Analysis of Phathom Pharmaceuticals
Is Phathom Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.50 per share, an increase next quarter of $0.54 per share, a decrease this year of $1.71 per share, and an increase next year of $1.35 per share.
Technical Analysis of Phathom Pharmaceuticals
Should I short Phathom Pharmaceuticals stock?
- PHAT Moving Average Covergence Divergence (MACD) indicator is 1.64, suggesting Phathom Pharmaceuticals is a Buy
- Phathom Pharmaceuticals Relative Strength Index (RSI) is 71.51, which suggest Phathom Pharmaceuticals is overbought
- The Bollinger Bands (25) for Phathom Pharmaceuticals is (13.56 - 18.4), which suggest Phathom Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Phathom Pharmaceuticals is (9.43 - 14.73), which suggest Phathom Pharmaceuticals is a Buy
* Phathom Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.